Choi et al. demonstrated that CXCR4, but not CXCR7, is essential for CXCL12-mediated metastasis, supporting CXCR4 inhibition as a strategy to prevent NSCLC progression (Choi et al., 2014). The gene discussed is CXCR4; the disease is non-small cell lung carcinoma.